Gastrointestinal Tumor Patients Live Longer on Cancer Drug

Your Health Matters

WEDNESDAY, March 28 (HealthDay News) — Extended treatment with the cancer drug Gleevec leads to improved survival rates in patients who have had surgery to remove a gastrointestinal stromal tumor and have a high risk of cancer recurrence, a new study says.

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave